Table 3.

Proinflammatory SNPs stratified by smoking status demonstrating the number of cases and controls, and Odds Ratio, 95%CI and p-values in an age-, race-adjusted additive model.

Gene	rs number	Smokers				Non-Smokers
		Cases/Controls	OR*	95% CI	p-value	Cases/Controls	OR*	95% CI	p-value
CD14	rs2569190	77/31	2.05	1.09–3.87	0.027	82/121	0.93	0.62–1.39	0.72
IL1A	rs17561	106/48	1.68	0.84–3.32	0.14	111/156	1.05	0.69–1.60	0.83
IL1R1	rs3917318	102/45	1.138	0.67–1.94	0.64	108/155	1.07	0.74–1.54	0.72
IL1B	rs3917365	99/44	1.63	0.78–3.42	0.19	105/146	1.03	0.62–1.73	0.90
IL6	rs1800797	104/43	1.28	0.66–2.46	0.46	110/155	1.05	0.67–1.64	0.83
	rs2069830	103/45	1.63	0.48–5.58	0.43	109/155	0.30	0.11–0.82	0.019
	rs2069832	101/45	0.69	0.35–1.35	0.28	109/152	0.80	0.51–1.26	0.34
MMP3	rs679620	103/46	0.98	0.58–1.65	0.93	110/157	1.01	0.71–1.43	0.97

* Adjusted for age and race (African-American, Caucasian, and other).